Annual short term debt:
$1.37M+$174.10K(+14.53%)Summary
- As of today (September 14, 2025), MLTX annual short term debt is $1.37 million, with the most recent change of +$174.10 thousand (+14.53%) on December 31, 2024.
- During the last 3 years, MLTX annual short term debt has fallen by -$13.63 million (-90.85%).
- MLTX annual short term debt is now -90.85% below its all-time high of $15.00 million, reached on December 31, 2021.
Performance
MLTX Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$1.55M+$118.00K(+8.24%)Summary
- As of today (September 14, 2025), MLTX quarterly short term debt is $1.55 million, with the most recent change of +$118.00 thousand (+8.24%) on June 30, 2025.
- Over the past year, MLTX quarterly short term debt has increased by +$228.30 thousand (+17.27%).
- MLTX quarterly short term debt is now -89.77% below its all-time high of $15.15 million, reached on March 31, 2022.
Performance
MLTX quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
MLTX Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | +17.3% |
| 3 y3 years | -90.8% | +100.0% |
| 5 y5 years | +2261.4% | +2819.0% |
MLTX Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | +793.2% | at high | >+9999.0% |
| 5 y | 5-year | -90.8% | +2261.4% | -89.8% | >+9999.0% |
| alltime | all time | -90.8% | +2261.4% | -89.8% | >+9999.0% |
MLTX Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.55M(+8.2%) |
| Mar 2025 | - | $1.43M(+4.4%) |
| Dec 2024 | $1.37M(+14.5%) | $1.37M(-5.0%) |
| Sep 2024 | - | $1.44M(+9.3%) |
| Jun 2024 | - | $1.32M(+1.3%) |
| Mar 2024 | - | $1.30M(+8.9%) |
| Dec 2023 | $1.20M(+679.9%) | $1.20M(+666.4%) |
| Sep 2023 | - | $156.30K(-1.2%) |
| Jun 2023 | - | $158.20K(+1.9%) |
| Mar 2023 | - | $155.20K(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $153.60K(-99.0%) | $153.60K(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $15.15M(+1.0%) |
| Dec 2021 | $15.00M(>+9900.0%) | $15.00M(>+9900.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $58.10K | $58.10K(+9.4%) |
| Sep 2020 | - | $53.10K |
FAQ
- What is MoonLake Immunotherapeutics annual short term debt?
- What is the all time high annual short term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual short term debt year-on-year change?
- What is MoonLake Immunotherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly short term debt year-on-year change?
What is MoonLake Immunotherapeutics annual short term debt?
The current annual short term debt of MLTX is $1.37M
What is the all time high annual short term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual short term debt is $15.00M
What is MoonLake Immunotherapeutics annual short term debt year-on-year change?
Over the past year, MLTX annual short term debt has changed by +$174.10K (+14.53%)
What is MoonLake Immunotherapeutics quarterly short term debt?
The current quarterly short term debt of MLTX is $1.55M
What is the all time high quarterly short term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly short term debt is $15.15M
What is MoonLake Immunotherapeutics quarterly short term debt year-on-year change?
Over the past year, MLTX quarterly short term debt has changed by +$228.30K (+17.27%)